In charge of regulatory and pharmaceutical affairs for seven years in two pharmaceutical companies of different sizes (Servier, EG LABO), then three years in a regulatory affairs consulting firm (A.R.C. Pharma), Lorraine acquired during that decade a range of expertise in regulatory strategy, registration, industrial transfer and MA acquisition on many projects overlapping with production, quality and business development.

Lorraine joined ATESSIA in 2017 as a Senior Regulatory and Pharmaceutical Affairs Advisor to bring her clients a practical approach.

She is involved in regulatory and pharmaceutical consulting, particularly in registration activities and technico-regulatory strategy, as well as in regulatory audits (due diligence).

Lorraine also provides services related to the quality of exploitant activities, more specifically the analysis of Product Quality Reviews (PQRs).

She is responsible for the design and compilation of MA (Modules 1 and 3) and pharmaceutical variation applications as well as managing complex multi-trade interdisciplinary projects.

She contributes to the regulatory intelligence service ATESSIA Intelligence as an editor for the Quality & CMC aspects.